Recent advances in surgical, immunosuppressive and monitoring protocols have led to the
significant improvement of overall one-year kidney allograft outcomes. Nonetheless, there …

Objectives: Describe the risk factors for developing chronic kidney disease. Review the
pathophysiology of chronic kidney disease. Outline the treatment and management options …

Atrial fibrillation (AF) is the most common cardiac arrhythmia and it is frequently encountered
in chronic kidney disease (CKD) subjects. CKD patients are already at high risk for …

Objectives: Describe the risk factors for developing chronic kidney disease. Review the
pathophysiology of chronic kidney disease. Outline the treatment and management options …

Purpose Direct oral anticoagulants (DOACs) are increasingly used in renal transplant
recipients (RTR), but relatively understudied in this population. We assess the safety of post …

(1) Background: We analyzed the association between atrial fibrillation or atrial flutter (AF)
and in-hospital mortality (IHM) among patients who underwent solid organ transplants in …

Anticoagulation therapy (AT) is fundamental in atrial fibrillation (AF) treatment but poses
challenges in implementation, especially in AF populations with elevated thromboembolic …

Background: The role of anticoagulation therapy for stroke prevention in older atrial
fibrillation (AF) patients with chronic kidney disease (CKD) remains unclear. Therefore, we …

The risk of arrhythmia and its management become increasingly complex as kidney disease
progresses. This presents a multifaceted clinical challenge. Our discussion addresses these …

No data are available on rivaroxaban use in renal transplant recipients and on its surmised
interaction with immunosuppressants. The aim was to investigate potential interactions …